Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives

Published: 12.02.2025

Navamedic ASA: Invitation to 2024 4th quarter presentation

Published: 10.02.2025

Navamedic ASA: Amendments to loan agreements with Observe Medical ASA

Published: 15.11.2024

Navamedic ASA: Mandatory notice of trade

Published: 06.11.2024

Navamedic launches Eroxon[®] in Finland

Published: 06.11.2024

Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business

Published: 31.10.2024